bioAffinity Technologies Announces CEO Presentation at Investor Conference

What Happened

• On September 3, 2026, bioAffinity Technologies, Inc. (BIAF) filed an 8‑K announcing that President and CEO Maria Zannes will give a corporate update and hold one‑on‑one investor meetings at the H.C. Wainwright 28th Annual Global Investment Conference, scheduled for September 14–16, 2026. The company attached a press release dated September 3, 2026, as Exhibit 99.1.

Key Details

• Filing date: September 3, 2026.
• Conference dates: September 14–16, 2026 (H.C. Wainwright 28th Annual Global Investment Conference).
• CEO/Presenter: Maria Zannes, President and CEO.
• Shares outstanding and market value as of Sept 2, 2026: 600,736 shares; aggregate market value ≈ $5.9 million (based on Nasdaq closing price).

Why It Matters

• Investor conferences are a primary venue for management to update investors and answer questions directly; this announcement signals an upcoming opportunity for new or existing investors to hear company developments firsthand.
• The filing also provides a current snapshot of the company’s float and market capitalization, which investors use to assess company size and liquidity.